Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma
The outlook for patients with advanced cutaneous T-cell lymphomas (CTCL); mycosis fungoides (MF) and Sézary syndrome (SS) remains poor and most systemic treatments provide short-lived remissions. Immunotherapy has provided a major cancer breakthrough, and the PORT trial was designed to investigate...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ferrata Storti Foundation
2026-07-01
|
| Serie: | Haematologica |
| Accesso online: | https://haematologica.org/article/view/14301 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
